Close Menu
Daily NewsDaily News
    Pages
    • Home
    • About
    • Meet the Daily News Team
    • Contact
    • Terms and Conditions
    • Privacy Policy
    Facebook X (Twitter) Instagram
    Facebook X (Twitter)
    Daily NewsDaily News
    Subscribe
    • News
    • Entertainment
    • Finance
    • Health
    • Lifestyle
    • UK Politics
    • Property
    • Technology
    • Travel
    • World
    Daily NewsDaily News
    Home » Latest » Veridix AI Launches Protocol Digitization Capabilities
    News

    Veridix AI Launches Protocol Digitization Capabilities

    Sam AllcockBy Sam Allcock14/08/20243 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit WhatsApp Copy Link
    Share
    Facebook Twitter LinkedIn Pinterest Email Reddit WhatsApp Copy Link

    New Technology Set to Transform Clinical Trial

    Veridix AI, a division of Emmes Group, has announced the launch of its groundbreaking protocol digitization technology. This new capability is designed to streamline the clinical trial study build process, reducing timelines by up to 30% and improving data accuracy.

    Enhancing Clinical Trial Efficiency

    Veridix AI’s protocol digitization is integrated into the Advantage eClinical Cloud platform. This advanced technology employs natural language processing (NLP) and artificial intelligence (AI) to convert unstructured clinical trial protocols into structured data elements. These elements include visit schedules, study cohorts, and electronic case report forms (eCRFs). By leveraging historical clinical trial data, Veridix AI’s system can generate visit schedules and predict eCRFs with over 82% accuracy.

    Addressing Manual Process Challenges

    Traditionally, clinical trial processes have been marred by slow, manual, and error-prone methods. The task of reviewing protocols to extract necessary study elements is no exception. Veridix AI’s new approach addresses these challenges by automating the protocol extraction process, thereby enhancing overall efficiency and data quality.

    Rama Kondru, CEO of Veridix AI, remarked, “The digitization of protocols represents a significant advancement in how protocol information is utilised throughout the clinical research lifecycle. By harnessing NLP and AI technologies, we are automating various aspects of the clinical trial process, marking a substantial leap forward in integrating technology into clinical research.”

    Future Developments and Impact

    Looking ahead, Veridix AI plans to further enhance its capabilities with future releases of Advantage eClinical Cloud. Upcoming features will include an embedded workflow for converting protocols into structured data elements and the automated creation of eCRFs, including edit checks based on AI predictions. These advancements are expected to continue improving the efficiency of clinical trial study builds.

    Sastry Chilukuri, CEO of Emmes Group, stated, “This innovative capability significantly accelerates the study build process, allowing our data managers to focus on more valuable tasks rather than on time-consuming manual processes. We have integrated this technology into over 40 new study builds across both our government and commercial projects. This underscores our dedication to advancing clinical trials through next-generation technology and AI.”

    Commitment to Innovation

    Veridix AI’s introduction of protocol digitization marks a pivotal moment in the evolution of clinical trial technology. By reducing the manual workload and enhancing accuracy, this new capability represents a significant step towards more efficient and reliable clinical trials. The deployment of this technology across a wide range of studies highlights Veridix AI’s ongoing commitment to leveraging advanced technology to improve clinical research outcomes.

    https://veridixai.com/

    Post Views: 503
    Follow on Google News Follow on Facebook Follow on X (Twitter)
    Share. Facebook Twitter LinkedIn Tumblr Email Reddit WhatsApp Copy Link
    Previous ArticleCrystal Lagoons Launches Stunning Lagoon Park in Bucharest
    Next Article Calibre Scientific Acquires Greyhound Chromatography
    Sam Allcock
    • Website
    • X (Twitter)
    • LinkedIn

    Related Posts

    By Sam Allcock26/03/2025

    BASE Project Gears Up for Digital Battery Passport Initiative

    By Sam Allcock18/03/2025

    UK and China Reignite Climate Talks to Tackle Global Emissions

    By Sam Allcock15/03/2025

    Dalai Lama Honoured with Gold Mercury Award 2025

    Top Stories

    Jill Lamontagne on a Few of America’s Most Challenging Environmental Issues

    08/05/2025

    Breaking: Homes in England are becoming more unaffordable

    01/04/2025

    ROE Connect: Forging Global Partnerships in Innovation

    31/03/2025

    Xenco Medical Earns Second Fast Company Innovation Award

    30/03/2025
    Topics
    • Accessories
    • Adventure
    • Aerospace & Defence
    • Animal
    • Animals & Pets
    • Art & Culture
    • Automotive
    • Awards
    • Banking
    • Books & Publishing
    • Business
    • Business & Retail
    • Career
    • Charity
    • Community
    • Culture & Art
    • Cybersecurity
    • Defence
    • Design & Innovation.
    • Economics
    • Economy
    • Education
    • Electronics
    • Employment
    • Energy
    • Entertainment
    • Environment
    • Event
    • Events & Festivals
    • Fashion
    • Fashion & Beauty
    • Festivals
    • Finance
    • food
    • Food & Beverage
    • Gaming
    • Health
    • Homes & Interiors
    • Hospitality
    • Hotels
    • Housing & Social Care
    • IT
    • Legal and Compliance
    • Lifestyle
    • Marketing & Advertising
    • Media
    • News
    • Pets
    • Property
    • Real Estate
    • Research & Development
    • Retail
    • social
    • Society & Culture
    • Sports
    • sustainability
    • Technology
    • Trade
    • Transport
    • Travel
    • UK Politics
    • Vehicle
    • Weather & Climate
    • Wildlife
    • World
    Facebook X (Twitter) LinkedIn
    • Home
    • About
    • Meet the Daily News Team
    • Contact
    • Terms and Conditions
    • Privacy Policy
    © 2025 dailyNews.

    Type above and press Enter to search. Press Esc to cancel.